| For: | Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2434-2457 [PMID: 34092968 DOI: 10.3748/wjg.v27.i20.2434] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i20/2434.htm |
| Number | Citing Articles |
| 1 |
Yongjian Guo, Jingqiang Wu, Licong Liang, Kangshun Zhu, Jingwen Zhou, Liteng Lin, Ye Chen, Bihui Cao, Mingji He, Hui Lian, Wensou Huang, Mingyue Cai. Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00604-4
|
| 2 |
Chiao-Yi CHEN, Bing-Shen HUANG, Ji-Hong HONG, Joseph Tung-Chieh CHANG, Min-Chi CHEN, Woung-Ru TANG, Shiow-Ching SHUN, Mei-Ling CHEN. Persistent Fatigue in Patients With Hepatocellular Carcinoma Receiving Radiotherapy. Journal of Nursing Research 2024; 32(2) doi: 10.1097/jnr.0000000000000606
|
| 3 |
So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak, Hye Jin Kang. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. Journal of Cancer Research and Clinical Oncology 2022; 148(9) doi: 10.1007/s00432-021-03788-z
|
| 4 |
Jing‐Long Cao, Shu‐Mei Li, Yan‐Jun Tang, Wen‐Shuang Hou, An‐Qi Wang, Tian‐Zhu Li, Cheng‐Hao Jin. Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells. Drug Development Research 2024; 85(2) doi: 10.1002/ddr.22165
|
| 5 |
Yibo He, Maher Ali Rusho, Soumya V. Menon, Mandeep Kaur, Majid S. Jabir, Sabrean Farhan Jawad, Thikra F. Hasan, Mazin A. A. Najm, Mohammed Abed Jawad, Ali J. Khelief. Advancements in radiobiology techniques and applications for personalized radiation therapy in nuclear medicine. Journal of Radioanalytical and Nuclear Chemistry 2024; 333(12) doi: 10.1007/s10967-024-09804-z
|
| 6 |
Maryam Asadat Hashemipour, Ali Ezadi, Ava Roshani, Amir Reza Gandjalikhan Nassab. Side Effects of Radiation Therapy in Patients with Head and Neck Cancer According to the Late Effects of Normal Tissues-Subjective Objective Management and Analytic Questionnaire. Meandros Medical and Dental Journal 2023; 24(3) doi: 10.4274/meandros.galenos.2023.10438
|
| 7 |
Juliana Camila Fischer Karnopp, Juliana Jorge, Jaqueline Rodrigues da Silva, Diego Boldo, Kristiane Fanti Del Pino Santos, Adriana Pereira Duarte, Gustavo Rocha de Castro, Ricardo Bentes de Azevedo, Ariadna Lafourcade Prada, Jesús Rafael Rodríguez Amado, Marco Antonio Utrera Martines. Synthesis, Characterization, and Cytotoxicity Evaluation of Chlorambucil-Functionalized Mesoporous Silica Nanoparticles. Pharmaceutics 2024; 16(8) doi: 10.3390/pharmaceutics16081086
|
| 8 |
Farag M.A. Altalbawy, Ahmed Hussein Zwamel, Gaurav Sanghvi, R. Roopashree, Mukesh Kumari, Aditya Kashyap, S. Gayathri, Rajashree Panigrahi. Interactions in hepatic tumor microenvironment: Potential targets and modulations for effective therapy. Pathology - Research and Practice 2025; 272 doi: 10.1016/j.prp.2025.156074
|
| 9 |
Xi Chen, Letao Lin, Guanyu Chen, Huzheng Yan, Zhenyu Li, Meigui Xiao, Xu He, Fujun Zhang, Yanling Zhang. High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.900671
|
| 10 |
Kangning Meng, Guanzhong Gong, Rui Liu, Shanshan Du, Yong Yin. Advances in gross tumor target volume determination in radiotherapy for patients with hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1346407
|
| 11 |
Anqi Zhang, Lei Gao. The Refined Application and Evolution of Nanotechnology in Enhancing Radiosensitivity During Radiotherapy: Transitioning from Gold Nanoparticles to Multifunctional Nanomaterials. International Journal of Nanomedicine 2023; doi: 10.2147/IJN.S436268
|
| 12 |
蕊雨 郭. Advances of High-Intensity Focused Ultrasound Ablation in the Treatment of Primary Liver Cancer. Advances in Clinical Medicine 2023; 13(03) doi: 10.12677/ACM.2023.133460
|
| 13 |
Lin Sun, Huangxing Cai, Tengchao Zhou, Hua Xiang, Lin Long. Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR‐101‐3p/Wee1 axis. Drug Development Research 2022; 83(4) doi: 10.1002/ddr.21914
|
| 14 |
Wei Xu, Guoqiang Guan, Renye Yue, Zhe Dong, Lingling Lei, Heemin Kang, Guosheng Song. Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy. Chemical Reviews 2025; 125(4) doi: 10.1021/acs.chemrev.4c00546
|
| 15 |
Haiqing Wang, Wentao Bo, Xielin Feng, Jinliang Zhang, Ge Li, Yan Chen. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. International Journal of Nanomedicine 2024; doi: 10.2147/IJN.S460844
|
| 16 |
Sabrina Y Almashni, Fady Bassem Fayek, Dannah C Javens, Michael T Boulis, Mina S Makary. Evolving and novel applications of artificial intelligence in interventional oncology. World Journal of Clinical Oncology 2026; 17(3): 113226 doi: 10.5306/wjco.v17.i3.113226
|
| 17 |
Christian N. Schill, William H. Smith. Liver Cancer - Multidisciplinary Approach. 2024; doi: 10.5772/intechopen.1005029
|
| 18 |
Ke Su, Xin Liu, Yue-Can Zeng, Junnv Xu, Han Li, Heran Wang, Shanshan Du, Huadong Wang, Jinbo Yue, Yong Yin, Zhenjiang Li. Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S521378
|
| 19 |
Lian-Qiang Han. Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91992-z
|
| 20 |
Rong Cong, Bo Chen, Sai-Nan Cheng, Yi-Rui Zhai, Fan Wu, Bing Feng, Le-Yao Wang, Zhao-Wei Chen, Yong-Jian Zhu, Xiao-Hong Ma, Xin-Ming Zhao. Early recurrence risk stratification of hepatocellular carcinoma receiving preoperative radiotherapy: Incorporating clinical and imaging features across treatment phases. World Journal of Gastroenterology 2026; 32(23): 118308 doi: 10.3748/wjg.v32.i23.118308
Abstract(74) |
Core Tip(85) |
Full Article(HTML)(306)
|
Full Article (PDF)-1851K(74)
|
Full Article with Cover (PDF)-2235K(82)
|
Full Article (XML)-155K(33)
|
Audio-198K(4)
|
Peer-Review Report-237K(28)
|
Answering Reviewers-198K(66)
|
Supplementary Material-347K(51)
|
Times Cited (0)
|
Total Visits (623)
|
Open
|
| 21 |
Weizhi Li, Hui Xue, Peijie Li, Xiaozhi Zhang. FOXP1-transcriptionally regulated AEG-1 enhances tumor cell stemness to promote hepatocellular carcinoma radioresistance. Molecular and Cellular Biochemistry 2025; 481(1) doi: 10.1007/s11010-025-05421-w
|
| 22 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1) doi: 10.14218/JCTH.2021.00179
|
| 23 |
Lin Qi, Manyin Zhao, Wenshu Li, Nan Mu, Yukun Yang, Zhaojie Yang, Aimin Lin. Development and validation of a nomogram for predicting specific mortality risk: A study of competing risk model based on real endometrial cancer patients. Journal of Obstetrics and Gynaecology Research 2024; 50(7) doi: 10.1111/jog.15957
|
| 24 |
Jeong Il Yu, Wonseok Kang, Gyu Sang Yoo, Myung Ji Goh, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jung Yong Hong, Ho Yeong Lim, Boram Park, Hee Chul Park. Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.888755
|
| 25 |
Afua A. Yorke, Matthew J. Nyflot, Smith Apisarnthanarax, Patty A. Sponseller, Stephen R. Bowen. Precision Radiation Therapy for Hepatocellular Carcinoma: Exploring the Clinical Utility of Functional Liver Avoidance Planning. Practical Radiation Oncology 2026; doi: 10.1016/j.prro.2026.03.008
|
| 26 |
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma. Cancers 2023; 15(13) doi: 10.3390/cancers15133347
|
| 27 |
Role of Radiotherapy in Liver Tumors: Recent Update. Forum of Clinical Oncology 2024; 15(1) doi: 10.2478/fco-2024-0006
|
| 28 |
Hon-Yi Lin, Chih-Chia Yu, Chen-Lin Chi, Chang-Kuo Wei, Wen-Yao Yin, Chih-En Tseng, Szu-Chin Li. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer. Cancers 2023; 15(16) doi: 10.3390/cancers15164131
|
| 29 |
Rui Xing, Jinping Gao, Qi Cui, Qian Wang. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.783236
|
| 30 |
Yan Luo. Radiobiological perspective on metrics for quantifying dose enhancement effects of High-Z nanoparticles. Frontiers in Nanotechnology 2025; 7 doi: 10.3389/fnano.2025.1603334
|
| 31 |
Yingze Hou, Can Zhu, Ge Ban, Zhean Shen, Yingbing Liang, Kun Chen, Chenbo Wang, Heng Shi. Advancements and Challenges in the Application of Metal-Organic Framework (MOF) Nanocomposites for Tumor Diagnosis and Treatment. International Journal of Nanomedicine 2024; doi: 10.2147/IJN.S463144
|
| 32 |
Dev Kashyap, Manish Kumar, Ayush Singh, Arnav Kansal, Amanpreet Kaur, Shruti Srivastava, Vipin Saini, Jagpreet Kour. Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma. Expert Review of Anticancer Therapy 2026; 26(1) doi: 10.1080/14737140.2025.2575017
|
| 33 |
Rachel Hogen, Tara Barry, Vijay Subramanian. Expanding Indications for Liver Transplantation in the Treatment of Hepatocellular Carcinoma. Current Oncology 2024; 31(8) doi: 10.3390/curroncol31080355
|
| 34 |
Dan Liu, Runtian Li, Mingzhu Li, Ying Liang, Zhao Wang, Yang Sun, Pengling Ge. Colon-Targeted astragalus polysaccharide nanoparticles prevent NAFLD-Driven hepatocarcinogenesis via microbiota remodeling and NF-κB Inhibition. Journal of Experimental & Clinical Cancer Research 2025; 44(1) doi: 10.1186/s13046-025-03608-z
|
| 35 |
Sakue Masuda, Toshitaka Tsukiyama, Yumiko Minagawa, Kazuya Koizumi, Makoto Kako, Takeshi Kinbara, Uojima Haruki. Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature. World Journal of Clinical Cases 2022; 10(8): 2591-2603 doi: 10.12998/wjcc.v10.i8.2591
|
| 36 |
Maher Hendi, Bin Zhang, Jie-Min Lv, Xiu-Jun Cai. Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life. World Journal of Psychiatry 2025; 15(5): 104995 doi: 10.5498/wjp.v15.i5.104995
Abstract(429) |
Core Tip(488) |
Full Article(HTML)(1821)
|
Full Article (PDF)-1026K(157)
|
Full Article with Cover (PDF)-4765K(300)
|
Full Article (XML)-128K(107)
|
Audio-2186K(9)
|
Peer-Review Report-195K(108)
|
Answering Reviewers-42K(100)
|
Supplementary Material-235K(99)
|
Times Cited (4)
|
Total Visits (3020)
|
Open
|
| 37 |
Yirui Zhai, Yefan Zhang, Fan Wu, Jianguo Zhou, Lingxia Xin, Feng Ye, Wei Sun, Huiying Zeng, Yan Song, Yongkun Sun, Wen Zhang, Shu-Lian Wang, Yuan Tang, Hui Fang, Pan Zhao, Yueping Liu, Ningning Lu, Shunan Qi, Hao Jing, Wenwen Zhang, Yongwen Song, Ye-Xiong Li, Liming Wang, Bo Chen. Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1594577
|
| 38 |
Liqiu Kou, Xiaolu Xie, Xiu Chen, Bo Li, Jun Li, Yaling Li. The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2023; 72(12) doi: 10.1007/s00262-023-03568-3
|
| 39 |
Jinhua Yang, Hanyu Jiang, Yujing Huang, Mingqiang Bao, Deqiang Zhang, Yijie Yan, Xinyi Li, Huijie Jia, Daokun Yang, Tiesuo Zhao.
Attenuated
Salmonella
carrying IL-21 expression plasmid enhances the efficacy of radiotherapy for hepatocellular carcinoma
. Journal of Drug Targeting 2026; doi: 10.1080/1061186X.2026.2702621
|
| 40 |
Jiaxi Zheng, Minghai Shao, Weifang Yang, Justin Ren, Xiaofeng Chen, Haihua Yang. Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis. International Immunopharmacology 2022; 112 doi: 10.1016/j.intimp.2022.109244
|